Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Cancer Lett. 2023 Mar 22;561:216141. doi: 10.1016/j.canlet.2023.216141

Table 2:

Exosome loaded small molecules for cancer treatment

Anticancer Small Molecule Source of Exosomes Model System Drug Load* Reference

Anthocyanidins Raw bovine milk In vitro ovarian cancer cell lines
In vivo ovarian cancer in mice
~20% [136]
Raw bovine milk In vitro lung, prostate, colon, breast, pancreatic, and ovarian cancer
In vivo lung cancer xenografts in mice
~20% [137]
Raw bovine milk In vivo colon cancer in mice ~20% [138]

Celastrol Raw bovine milk In vitro lung cancer cell lines
In vivo lung cancer xenografts in mice
18–20% [139]

Curcumin Raw bovine milk In vitro breast, lung, and cervical cancer cell lines
In vivo cervical tumor xenografts
18–24% [135]
Raw bovine milk In vitro breast cancer cell lines 2 μM [116]
Pasteurized skim milk In vitro colorectal cancer cell lines 9% [140]

Raw Bovine Milk In vitro breast cancer cell lines EE ~70% [141]
Doxorubicin Raw Bovine Milk In vitro breast and lung cancer cell lines None reported [142]
Raw Bovine Milk In vitro and in vivo oral squamous cell carcinoma 13.4% [143]

Paclitaxel Raw bovine milk In vitro lung cancer cells ~8% [81]
Raw bovine milk In vitro breast cancer cell lines ~30% [144]
Bovine colostrum In vitro lung cancer cell lines
In vivo lung cancer in mice
25–75% [145]

Resveratrol Raw bovine milk In vitro breast cancer cell lines 15 M [116]

Withaferin Raw bovine milk In vitro lung cancer
lung cancer tumors in mice
[81]
*

Reported as w/w percent drug load unless otherwise indicated. EE = encapsulation efficiency.